{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:14:28Z","timestamp":1790633668420,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.dld.2022.06.019","type":"journal-article","created":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T07:04:30Z","timestamp":1657436670000},"page":"1153-1161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)"],"prefix":"10.1016","volume":"54","author":[{"given":"Marco","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8049-0115","authenticated-orcid":false,"given":"Antonietta Gerarda","family":"Gravina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Henry","family":"Eusebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Frazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elton","family":"Dajti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco Maurizio","family":"Zagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello Fabio","family":"Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Luzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ricciardiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Frulloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Repici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Lamazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Cengia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ciliberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Luisa","family":"Conigliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Da Massa Carrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastianello","family":"German\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2022.06.019_bib0001","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global Prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.06.019_bib0002","article-title":"Treatment of Helicobacter pylori infection: a clinical practice update","volume":"48","author":"Zagari","year":"2018","journal-title":"Eur J ClinInvest"},{"key":"10.1016\/j.dld.2022.06.019_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.06.019_bib0004","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2022.06.019_bib0005","doi-asserted-by":"crossref","first-page":"l6483","DOI":"10.1136\/bmj.l6483","article-title":"Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis","volume":"367","author":"Eusebi","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2022.06.019_bib0006","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG clinical guideline: management of dyspepsia","volume":"112","author":"Moayyedi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0007","doi-asserted-by":"crossref","first-page":"e12693","DOI":"10.1111\/hel.12693","article-title":"Helicobacter pylori \u201cTest-and-Treat\u201d strategy with urea breath test: a cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative","volume":"25","author":"Beresniak","year":"2020","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0008","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/17474124.2016.1142872","article-title":"Management of NSAID-associated peptic ulcer disease","volume":"10","author":"Melcarne","year":"2016","journal-title":"Exp Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.06.019_bib0009","first-page":"236","article-title":"Diagnosis and treatment of peptic ulcer disease and H. pylori infection","volume":"91","author":"Fashner","year":"2015","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.dld.2022.06.019_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.dld.2022.06.019_bib0011","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ajg.2015.98","article-title":"Peptic ulcer bleeding risk. The role of Helicobacter pylori Infection in NSAID\/Low-Dose Aspirin Users","volume":"110","author":"Sostres","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0012","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1523-5378.2008.00617.x","article-title":"Helicobacter pylori infection and iron stores: a systematic review and meta-analysis","volume":"13","author":"Muhsen","year":"2008","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0013","first-page":"886","article-title":"Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis","volume":"16","author":"Qu","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0014","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/pgmj.2009.089987","article-title":"Iron deficiency anaemia can be improved after eradication of Helicobacter pylori","volume":"86","author":"Huang","year":"2010","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.dld.2022.06.019_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/00365521003663670","article-title":"Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials","volume":"45","author":"Yuan","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0016","first-page":"1924","article-title":"Effect of Helicobacter pylori eradication on iron deficiency","volume":"123","author":"Zhang","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.dld.2022.06.019_bib0017","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.3748\/wjg.v24.i29.3204","article-title":"Helicobacter pylori and extragastric diseases: A review","volume":"24","author":"Gravina","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0018","first-page":"E3887","article-title":"Extra-gastric manifestations of Helicobacter pylori Infection","volume":"9","author":"Gravina","year":"2020","journal-title":"J ClinMed"},{"key":"10.1016\/j.dld.2022.06.019_bib0019","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1128\/IAI.01258-09","article-title":"Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media","volume":"78","author":"Senkovich","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.dld.2022.06.019_bib0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/08880018.2013.783144","article-title":"The role of prohepcidin in anemia due to Helicobacter pylori infection","volume":"30","author":"Ozkasap","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.dld.2022.06.019_bib0021","doi-asserted-by":"crossref","first-page":"E2141","DOI":"10.3390\/nu11092141","article-title":"Association between Active H. pylori infection and iron deficiency assessed by serum hepcidin levels in school-age children","volume":"11","author":"Mendoza","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.dld.2022.06.019_bib0022","first-page":"22","article-title":"An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia","author":"Hudak","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0023","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMcp1113996","article-title":"Vitamin B12 deficiency","volume":"368","author":"Stabler","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2022.06.019_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2011.00892.x","article-title":"Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review","volume":"17","author":"Lahner","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0025","doi-asserted-by":"crossref","first-page":"12818","DOI":"10.3748\/wjg.v20.i36.12818","article-title":"Hematologic manifestations of Helicobacter pylori infection","volume":"20","author":"Campuzano-Maya","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0026","first-page":"598","article-title":"[Chronic autoimmune gastritis\u00a0: a multidisciplinary management]","volume":"74","author":"Valdes-Socin","year":"2019","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.dld.2022.06.019_bib0027","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1523-5378.2007.00477.x","article-title":"Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura","volume":"12","author":"Kodama","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0028","first-page":"2939","article-title":"Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients","volume":"118","author":"Asahi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2022.06.019_bib0029","doi-asserted-by":"crossref","first-page":"12781","DOI":"10.3748\/wjg.v20.i36.12781","article-title":"Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment","volume":"20","author":"Testerman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1399-0039.2009.01214.x","article-title":"Single nucleotide polymorphism of interleukin-1beta associated with Helicobacter pylori infection in immune thrombocytopenic purpura","volume":"73","author":"Satoh","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.dld.2022.06.019_bib0031","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09537100500462487","article-title":"Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura","volume":"17","author":"Suvajdzi\u0107","year":"2006","journal-title":"Platelets"},{"key":"10.1016\/j.dld.2022.06.019_bib0032","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12185-008-0138-8","article-title":"Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura","volume":"88","author":"Jackson","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.dld.2022.06.019_bib0033","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/gut.49.3.341","article-title":"The significance of cagA(+) Helicobacter pylori in reflux oesophagitis","volume":"49","author":"Warburton-Timms","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.06.019_bib0034","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/apt.16585","article-title":"Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications","volume":"54","author":"Zamani","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cgh.2007.08.010","article-title":"Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis","volume":"5","author":"Rokkas","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.06.019_bib0036","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1111\/j.1572-0241.2002.07116.x","article-title":"Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies","volume":"97","author":"Laine","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0037","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ajg.2009.734","article-title":"Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis","volume":"105","author":"Yaghoobi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0038","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1523-5378.2011.00846.x","article-title":"Effects of Helicobacter pylori eradication on gastroesophageal reflux disease","volume":"16","author":"Qian","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0039","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.2001.29332","article-title":"Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease","volume":"121","author":"Moayyedi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.06.019_bib0040","first-page":"1401","article-title":"Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety","volume":"90","author":"Kuipers","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0041","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2022.06.019_bib0042","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2005.086579","article-title":"Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK","volume":"55","author":"Garc\u00eda Rodr\u00edguez","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.06.019_bib0043","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.3748\/wjg.v20.i34.11962","article-title":"Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD","volume":"20","author":"Mukaisho","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0044","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1177\/2050640618800628","article-title":"Prevalence of Helicobacter pylori infection in sexual partners of H. pylori-infected subjects: Role of gastroesophageal reflux","volume":"6","author":"Sgambato","year":"2018","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2022.06.019_bib0045","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3748\/wjg.v21.i4.1305","article-title":"Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis","volume":"21","author":"Ferwana","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0046","first-page":"58","article-title":"Non-invasive tests for the diagnosis of Helicobacter pylori: state of the art","volume":"89","author":"Kayali","year":"2018","journal-title":"Acta Biomed"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2022.06.019_bib0047","doi-asserted-by":"crossref","first-page":"e12641","DOI":"10.1111\/hel.12641","article-title":"Review: Diagnosis of Helicobacter pylori infection","volume":"24","author":"Makristathis","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0048","article-title":"Non-invasive diagnostic tests for Helicobacter pylori infection","volume":"3","author":"Best","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2022.06.019_bib0049","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1572-0241.2006.00668.x","article-title":"Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis","volume":"101","author":"Gisbert","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1523-5378.2010.00757.x","article-title":"Accuracy of monoclonal stool tests for determining cure of Helicobacter pylori infection after treatment","volume":"15","author":"Calvet","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0051","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2036.2004.02021.x","article-title":"Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole","volume":"20","author":"Levine","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0052","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/00365520410007944","article-title":"Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection","volume":"39","author":"Asfeldt","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0053","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ajg.2011.2","article-title":"Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression","volume":"106","author":"S\u00e1nchez-Delgado","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0054","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.dld.2015.06.010","article-title":"Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015","volume":"47","author":"Zagari","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2022.06.019_bib0055","first-page":"206","article-title":"Comparison of Helicobacter pylori stool antigen, salivary IgG, serum IgG, and serum IgM as diagnostic markers of H. pylori infection in children","volume":"11","author":"Darma","year":"2019","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.dld.2022.06.019_bib0056","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2022.06.019_bib0057","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.annpat.2018.03.009","article-title":"Diagnosis of Helicobacter pylori infection on gastric biopsies: Standard stain, special stain or immunohistochemistry?","volume":"38","author":"Benoit","year":"2018","journal-title":"Ann Pathol"},{"key":"10.1016\/j.dld.2022.06.019_bib0058","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2022.06.019_bib0059","first-page":"1962","article-title":"Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test","volume":"90","author":"el-Zimaity","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1523-5378.1996.tb00048.x","article-title":"The best gastric site for obtaining a positive rapid ureas test","volume":"1","author":"Woo","year":"1996","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0061","doi-asserted-by":"crossref","first-page":"644","DOI":"10.11622\/smedj.2014178","article-title":"The use of a second biopsy from the gastric body for the detection of Helicobacter pylori using rapid urease test","volume":"55","author":"Wong","year":"2014","journal-title":"Singapore Med J"},{"key":"10.1016\/j.dld.2022.06.019_bib0062","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1099\/jmm.0.47768-0","article-title":"Urease-positive bacteria in the stomach induce a false-positive reaction in a urea breath test for diagnosis of Helicobacter pylori infection","volume":"57","author":"Osaki","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.dld.2022.06.019_bib0063","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.3748\/wjg.v23.i14.2453","article-title":"Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?","volume":"23","author":"Ierardi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0064","doi-asserted-by":"crossref","first-page":"E723","DOI":"10.3390\/antibiotics9100723","article-title":"Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-Year scenario in Southern Italy","volume":"9","author":"Losurdo","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.dld.2022.06.019_bib0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/00365521.2018.1464596","article-title":"Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016","volume":"53","author":"Fiorini","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0066","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.06.019_bib0067","doi-asserted-by":"crossref","first-page":"e12570","DOI":"10.1111\/hel.12570","article-title":"Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori","volume":"24","author":"Nyssen","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0068","doi-asserted-by":"crossref","first-page":"e12502","DOI":"10.1111\/hel.12502","article-title":"The \u201cthree-in-one\u201d formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice","volume":"23","author":"Zagari","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0069","first-page":"264","article-title":"Effectiveness and Safety of Pylera\u00ae in patients infected by Helicobacter pylori: a multicenter, retrospective, real life study","volume":"36","author":"Tursi","year":"2018","journal-title":"DigDis"},{"key":"10.1016\/j.dld.2022.06.019_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.15403\/jgld.2014.1121.262.itl","article-title":"Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe","volume":"26","author":"Di Ciaula","year":"2017","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.dld.2022.06.019_bib0071","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.dld.2017.10.009","article-title":"Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study","volume":"50","author":"De Francesco","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2022.06.019_bib0072","doi-asserted-by":"crossref","first-page":"e12694","DOI":"10.1111\/hel.12694","article-title":"Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study","volume":"25","author":"Romano","year":"2020","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0073","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009034.pub2","article-title":"Sequential versus standard triple first-line therapy for Helicobacter pylori eradication","author":"Nyssen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2022.06.019_bib0074","doi-asserted-by":"crossref","first-page":"f4587","DOI":"10.1136\/bmj.f4587","article-title":"Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy","volume":"347","author":"Gatta","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2022.06.019_bib0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MEG.0000000000001102","article-title":"Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice","volume":"30","author":"Fiorini","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.06.019_bib0076","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/gutjnl-2015-310142","article-title":"Sequential therapy for 10\u2005days versus triple therapy for 14\u2005days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial","volume":"65","author":"Liou","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.06.019_bib0077","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008337.pub2","article-title":"Optimum duration of regimens for Helicobacter pylori eradication","author":"Yuan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2022.06.019_bib0078","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2012.05083.x","article-title":"Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?","volume":"35","author":"McNulty","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0079","doi-asserted-by":"crossref","first-page":"e14396","DOI":"10.1097\/MD.0000000000014396","article-title":"High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dld.2022.06.019_bib0080","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v26.i32.4846","article-title":"Current status of Helicobacter pylori eradication and risk factors for eradication failure","volume":"26","author":"Yan","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0081","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2012.05211.x","article-title":"Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection","volume":"36","author":"McNicholl","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0082","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12392","article-title":"Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies","volume":"22","author":"Gisbert","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0083","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2169\/internalmedicine.2521-18","article-title":"Efficacy of vonoprazan for Helicobacter pylori eradication","volume":"59","author":"Kiyotoki","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.dld.2022.06.019_bib0084","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jac\/dky469","article-title":"Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication","volume":"74","author":"De Francesco","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.dld.2022.06.019_bib0085","first-page":"409","article-title":"Worldwide H. pylori antibiotic resistance: a systematic review","volume":"19","author":"De Francesco","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.dld.2022.06.019_bib0086","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/antibiotics10010013","article-title":"European registry on helicobacter pylori management: effectiveness of first and second-line treatment in Spain","volume":"10","author":"Caldas","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.dld.2022.06.019_bib0087","first-page":"903","article-title":"Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015","volume":"47","author":"Zagari","year":"2015","journal-title":"DigLiverDis"},{"key":"10.1016\/j.dld.2022.06.019_bib0088","first-page":"22","article-title":"Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea","author":"Kim","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0089","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apt.13712","article-title":"Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection","volume":"44","author":"Chen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0090","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1365-2036.2006.03149.x","article-title":"Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures","volume":"24","author":"Gisbert","year":"2006","journal-title":"Aliment PharmacolTher"},{"key":"10.1016\/j.dld.2022.06.019_bib0091","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1365-2036.2012.05117.x","article-title":"Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0092","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.06.019_bib0093","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1053\/j.gastro.2018.06.047","article-title":"Efficacies of genotypic resistance-guided vs empirical therapy for refractory helicobacter pylori infection","volume":"155","author":"Liou","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.06.019_bib0094","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819874922","article-title":"Susceptibility-guided therapy for Helicobacter pylori infection treatment failures","volume":"12","author":"Yu","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2004.01910.x","article-title":"High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection","volume":"19","author":"Cammarota","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0096","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/MEG.0000000000000960","article-title":"Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection","volume":"29","author":"Costa","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.06.019_bib0097","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cgh.2012.12.007","article-title":"Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection","volume":"11","author":"Fiorini","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.06.019_bib0098","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2036.2000.00685.x","article-title":"Efficacy of a multistep strategy for Helicobacter pylori eradication","volume":"14","author":"Gasbarrini","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0099","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/apt.12089","article-title":"Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations","volume":"36","author":"Tay","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0210-5705(02)70283-5","article-title":"Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study","volume":"25","author":"Vicente","year":"2002","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.06.019_bib0101","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1007\/s10620-006-9302-2","article-title":"Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure","volume":"51","author":"Yahav","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2022.06.019_bib0102","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/jac\/dkv155","article-title":"Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection","volume":"70","author":"L\u00f3pez-G\u00f3ngora","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.dld.2022.06.019_bib0103","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2036.2006.02993.x","article-title":"Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin","volume":"24","author":"Miehlke","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.06.019_bib0104","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/1751-2980.12432","article-title":"Efficacy and safety of high-dose dual therapy for Helicobacter pylori rescue therapy: a systematic review and meta-analysis","volume":"17","author":"Gao","year":"2016","journal-title":"J Dig Dis"},{"key":"10.1016\/j.dld.2022.06.019_bib0105","doi-asserted-by":"crossref","first-page":"e14396","DOI":"10.1097\/MD.0000000000014396","article-title":"High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: a systematic review and meta-analysis","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dld.2022.06.019_bib0106","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2050640620972615","article-title":"European Registry on Helicobacter pylori management: single-capsule bismuth quadruple therapy is effective in real-world clinical practice","volume":"9","author":"Nyssen","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2022.06.019_bib0107","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCG.0000000000000540","article-title":"Rifabutin triple therapy is effective in patients with multidrug-resistant strains of Helicobacter pylori","volume":"52","author":"Fiorini","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2022.06.019_bib0108","first-page":"22","article-title":"Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains","author":"Fiorini","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2022.06.019_bib0109","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.3390\/antibiotics9030121","article-title":"Antibiotic resistance and therapy outcome in H. pylori eradication failure patients","volume":"9","author":"Saracino","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.dld.2022.06.019_bib0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jmii.2013.03.010","article-title":"Clinical application of probiotics in the treatment of Helicobacter pylori infection \u2013 a brief review","volume":"47","author":"Patel","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.dld.2022.06.019_bib0111","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/2050640615617358","article-title":"Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events","volume":"4","author":"McFarland","year":"2016","journal-title":"United Eur Gastroenterol J"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822005588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822005588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:19:37Z","timestamp":1761625177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822005588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":111,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1590865822005588"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.06.019","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}